(Difference between revisions)

Contents 1 Main Goal 2 Rationale 2.1 Synechocystis PCC 6803 2.2 Lux Operon 3 Experimental Strategy 3.1 Splitting the Lux operon and choosing promoters 3.2 Building constructs 3.2.1 pSB1C3_IntK 3.2.2 pSB1A3_IntC (Utah 2010 iGEM Team integration plasmid) 3.2.3 pSB1C3_IntS 4 References

Main Goal

Natural cycles have always fascinated mankind, probably due to the mysterious mechanisms involved in them and the power they exert in our everyday life. Since the dawn of synthetic biology, engineering oscillatory systems has been a recurrent topic, being Ellowitz's repressilator a classical example. Nevertheless, to date no iGEM team has accomplished the implementation of a robust oscillatory system. That will be our challenge for this year's iGEM project.

To reach our goal we designed a synthethic circuit that links to the endogenous circadian rhythm of Synechocystis PCC6803. As a proof of concept we are going to engineer the first light-rechargeable biological lamp: Synechocystis PCC 6803 cells that emit light only by night while recovering and producing the substrates during the day. We strongly believe this will serve as an enabling tool to any project requiring time control over a biological behaviour independently of the user's input.

Furthermore, the characterization of this chassis is a fundamental step to explore new systems with minimal inputs to replace E. coli, for example, in the biotechnological industry in order to achieve greener processes.

Rationale

Synechocystis PCC 6803

Cyanobacteria are prokaryotic photoautotrophs and they are believed to have evolved oxygenic photosynthesis about 2.4 billion years ago 1. Although this biochemical breakthrough can not be understated, several cyanobacteria species also play a crucial role in the planet nitrogen cycle as marine diazotrophs 2. Cyanobacteria are found almost in every environment in earth´s surface and interestingly, they are one of the few prokaryotes known to have circadian rhythms accounting for their photosyntethic lifestyle 3.

Synechocystis PCC6803 is a gram negative non-filamentous cyanobacteria and it was the third prokaryote and the first photoautotroph whose genome was sequenced. Consequently, it has become a model organism as its genetic background has been widely studied.

Given the reasons mentioned above, it is of no surprise that Synechocystis PCC6803 (among other cyanobacteria) has been extensively used for biotechnological applications and proposed as the “green E.coli”4.

With the dawn of Synthetic Biology, research has made use of Synechocystis for commodity chemicals production and detection of water soluble pollutants among other applications5,6.

While aware of these practical applications, we (UC_Chile) are particularly interested in the well characterized circadian behavior of this chassis 7 and its implications. There are several genes known to oscillate in a daily basis, most of them related to respiration, photosynthesis and energy metabolism 8, and it has been shown that reporter systems using these promoters show a similar expression pattern 9.

Lastly, there are a lot of biobricks designed especially for Synechocystis or derived from its genetic information by previous iGEM teams (references). However, sadly no one has characterized them in this chassis and the registry lacks a set of tools for its transformation with standard biological parts. Moreover, to our knowledge, no iGEM team has ever accomplished a successful direct Synechocystis transformation with naked DNA.

Lux Operon

The lux operon is a group of genes that are responsible for density-dependent bioluminescent behavior in various prokariotic organisms such as Vibrio fischeri and Photorabdus luminescens 12. In V. fischeri, the operon is composed of 8 genes: LuxA and LuxB encode for the monomers of a heterodimeric luciferase; LuxC, LuxD and LuxE code for fatty acid reductases enzymes and LuxR and LuxI are responsible for the regulation of the whole operon 13.

Lastly LuxG is believed to act as a FMNH2 dependent FADH reductase, although luminescence is barely affected in its absence 14. The n-decanal ( n= 9 to 14) substrate oxidization to n-decanoic acid by the LuxAB heterodimer is coupled with the reduction of FMNH to FMNH2 and the release of oxygen and light.

The carboxylic group of the product is then reduced to aldehyde by CDE proteins allowing the reaction to start over 15.

LuxAB genes have been widely used as reporters dependent on the addition of n-decanal to the culture media 16 and in 2010, the Cambridge iGEM team engineered LuxABCDEG to an E. coli-optimized biobrick format, uncoupling it from the LuxR and LuxI regulation.

As a team we decided to work with this operon for a number of reasons, first of all, the bioluminescence produced by this pathway is much stronger than other systems from the registry (i.e XFPs). Moreover, the light production does not depend on a single peptide but on a whole pathway involving several genes, which makes it much more tunable, for instance, decoupling in time the substrate recovery from the luciferase reaction itself.

Experimental Strategy

We have devised different strategies to achieve bioluminescence controlled under circadian rhythms. Here we describe the strategies used for building the constructs to reach our goals.

Splitting the Lux operon and choosing promoters

We decided that we would separate LuxAB (the luciferase part of the operon) and LuxCDEG (the substrate producing enzymes LuxCDE with LuxG the FMNH2/FMN reducing enzyme) to allow phase-dependent expression of the parts. Using specific promoters of Synechocystis PCC. 6803 we can have fine-tunning of the production of bioluminescence. Recent work on global gene expression in Synechocystis aided on finding adecuate promoters 7, 8 . (Images at right from cited papers.)

To try our approach, we selected various promoters which could serve the purpose. Our rational for selecting candidate promoters involved amplitude of oscillation, peak activity, hour, absence of restriction sites, predicted strength of promoter according to the role of the gene and reproducibility between experiments (based on the literature available). We looked for promoters which would have peak expression nearby dusk hours and that were slightly out of phase to optimize production of bioluminescence according to our mathematical models. We prioritized promoters from genes that would be involved in central energetic metabolism as we believe that their expression would be most robust and reliable.

We choose the transaldolase promoter to direct the expression of the LuxAB genes and we found a couple of other promoters which filled the other requirements from above. Pcaa3 and PsigE, the former being already in Biobrick format (courtesy from the Utah team iGEM 2010).

Building constructs

When confronted with the different available strategies to express the genes from the Lux operon in Synechocystis, we concluded that the one that best suits our need is by using integration plasmids. The reason for this is that the available plasmids that replicate in Synechocystis are very large (8 Kb) without even considering the genes we need to include in the constructs (that would sum up to a final 16 Kb aproximately). Such a large plasmid would prove very difficult to handle through molecular biology techniques, let alone transform Synechocystis.
Using integration plasmids also proposes an additional advantage, that is to produce successive integrations which allow accumulation of different desirable elements in the genome. Integration in Synechocystis is undergone through double recombination of homologous DNA which also allows interruption of genes if wanted. In our case we have designed our system to produce suceptibility to copper as a biosafety measure to have further control over our recombinant Synechocystis.

We designed two constructs that have different recombination locations in the Synechocystis chromosome. We named them according to what Utah iGEM team from 2010 proposed for naming conventions:

pSB1C3_IntK

[http://partsregistry.org/Part:BBa_K743006 BBa_K743006]

This construct is an integrative plasmid which targets neutral recombination sites (slr0370 and sll0337). We selected this locus because it has been extensively used in the literature ( 11) and it shown to have no deleterious effects on Synechocystis viability. We selected Kanamycin resistance as our selectable marker.
Using this backbone we have decided to put LuxAB under the transaldolase promoter.We have choose the transaldolase promoter to express the luciferase part of the operon, as in the literature the promoter is described as having a peak of expression at 2 hours past dusk, which we believe is just the right timing to "turn on the lamp".
We've found 2 versions of the bacterial luciferase which we will use on this construct. The first one is of Photorhabdus luminiscent K216008 from the 2009 Edinburgh iGEM team and the second one is part from the LuxBrick (K325909 from the 2010 Cambridge iGEM team) and originally comes from Vibrio fisherii but has been "E.coli optimized".

pSB1A3_IntC (Utah 2010 iGEM Team integration plasmid)

<p>We plan on using this plasmid to express the LuxCDEG contructs under the regulation of the Pcaa3 and PsigE promoters mentioned above. [http://partsregistry.org/wiki/index.php?title=Part:BBa_K390200 pSB1A3_IntC].

pSB1C3_IntS

Due to issues mentioned in the results page we designed a new plasmid backbone. This is an integration plasmid which makes Synechocystis susceptible to copper concentrations higher than 0.75 uM 10 by disrupting the CopS gene. We believe that this strategy serves as a biosafety measure to avoid the possibility of having a leakage of recombinant DNA to the environment. The [http://partsregistry.org/Part:BBa_K743010 plasmid] uses Spectynomycin as a selectable marker.

We plan on expressing LuxCDEG under the control of the promoters Pcaa3 and PsigE (mentioned above). These promoters have peak activities 1 hour before dusk. Based on our modelling we believe that we might enhance bioluminescence yield initially by setting the substrate production/regeneration part of the operon prior to the expression of the luciferase.

References